Skip Navigation
  • The MHH
  • International office
  • Emergency numbers
  • Patients & Visitors
  • Facilities & Departments
    • Facilities & Departments
    • MHH Clinical departments
    • MHH-Institutes
    • Clinical departments and institutes sorted by center
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
  • Studying at MHH
    • Studying at MHH
    • All degree programs
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
  • Careers
Welcome to the MHH News
Searched for service. Found 118 results in 3 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • »
News

The path to personalised hepatitis D treatment

Relevance: 65%
 

blueprint for personalised infectious medicine and help bring other viral diseases under control. SERVICE: For more information, contact Professor Dr Heiner Wedemeyer, wedemeyer.heiner@mh-hannover.de, telephone

News

Prognosis for effectiveness of leukaemia therapy possible eleven months earlier

Relevance: 65%
 

donor lymphocytes is successfully initiated in the patients," the haematologists are pleased to say. SERVICE: For further information , please contact Dr Christian Schultze-Florey at schultze-florey.christ

News

MHH: New test improves diagnosis of rare liver disease

Relevance: 65%
 

and the Department of Neurology with Clinical Neurophysiology were also involved in the project. SERVICE: For further informatio n, please contact PD Dr. Richard Taubert, taubert.richard@mh-hannover.de

News

MHH: New test to make gene therapy safer

Relevance: 65%
 

supported by the German Research Foundation within the framework of the REBIRTH research network. SERVICE: For further information , please contact Dr Michael Rothe, rothe.michael@mh-hannover.de , phone

News

Millions in funding for Hanover's implant research

Relevance: 65%
 

will contribute significantly to a further increase in future implant and thus patient safety. SERVICE: For further information , please contact Professor Dr Meike Stiesch, stiesch.meike@mh-hannover.de

News

Domestic blood collection should relieve the burden of chronically ill

Relevance: 63%
 

specialist areas and other care offerings – for example, outpatient or inpatient care, emergency services or medical research. “Until now, we sometimes expect participants in our clinical trials to travel

News

Hannover will continue to be one of the international pacemakers in the future

Relevance: 63%
 

transplant medicine, where we urgently need highly motivated and especially qualified nursing staff. SERVICE: For more information, contact Prof. Dr. Moritz Schmelzle, schmelzle.moritz@mh-hannover.de , phone

News

Search for alternatives to animal testing in research continues to be promoted

Relevance: 63%
 

"Especially in this area, we could avoid many experiments on living animals with our chip systems." SERVICE: For information on how research is currently working to reduce, improve or completely replace animal

News

HBG has a new managing director

Relevance: 63%
 

implementation of the measures to be carried out. The joint shareholders of HBG are MHH and DBHN. SERVICE: For further information, please contact: Hannover Medical School Stefan Zorn, Head of Communications

News

MHH researcher wants to develop gene therapy against hearing and balance disorders

Relevance: 63%
 

the University Medical Center of the University of Kansas (USA) and Boston Children's Hospital. SERVICE: For further information , please contact Professor Dr. Dr. Axel Schambach, schambach.axel@mh-hannover

  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • »
Imprint Intranet Contact Privacy Accessibility
The MHH Hospital is a maximum care hospital with a nationwide catchment area. The university teaches medicine, dentistry, biochemistry, biomedicine, midwifery and health sciences. The main research areas are Transplantation and Stem Cell Research / Regenerative Medicine, Infection and Immunology Research, Biomedical Engineering and Implant Research.

   

Information about

Blood donation service MHH-Alumni e.V.

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2025 Medizinische Hochschule Hannover
Nach oben scrollen